Get an email when this journal's indexing changes
Added to or removed from Scopus, Web of Science, ABDC, DOAJ, FT50, UT Dallas or ONOS. One confirmation click; unsubscribe anytime.
Journal of Advanced Biotechnology and Experimental Therapeutics is Scopus-indexed (Q3, CiteScore 2.1), DOAJ. Published by Bangladesh Society for Microbiology, Immunology and Advanced Biotechnology.
Checked against the index lists dated .
ISSN 2616-4760Verify ISSN ↗
Publisher: Bangladesh Society for Microbiology, Immunology and Advanced Biotechnology
Cost to publish: Checking DOAJ for article charges…
| Subject area | Rank | Pctile | Q |
|---|---|---|---|
| Plant Science | 301 / 541 | 44th | Q3 |
| Biochemistry, Genetics and Molecular Biology (all) | 143 / 223 | 36th | Q3 |
| Applied Microbiology and Biotechnology | 96 / 134 | 28th | Q3 |
Not listed in: Web of Science, ABDC, ABS / AJG, FT50, UT Dallas, ONOS (subscription), ONOS (APC covered)
Yes — actively indexed in Scopus, coverage 2018–present, best quartile Q3, CiteScore 2.1.
Journal of Advanced Biotechnology and Experimental Therapeutics is Q3 in Plant Science (rank 301 of 541), Q3 in Biochemistry, Genetics and Molecular Biology (all) (rank 143 of 223) and Q3 in Applied Microbiology and Biotechnology (rank 96 of 134), by CiteScore 2025.
Journal of Advanced Biotechnology and Experimental Therapeutics is not in the Web of Science Core Collection (SCIE, SSCI, AHCI or ESCI), so Clarivate publishes no Journal Impact Factor for it. Its Scopus CiteScore is 2.1, quartile Q3, 44th percentile. Any "impact factor" quoted elsewhere is not the Clarivate metric. Its SCImago Journal Rank (SJR, a free Scopus-based metric) is 0.230, quartile Q3, with an H-index of 14.
The publisher lists an article processing charge of about US$169 for open access (source: OpenAlex). Many journals also publish by the subscription route at no cost to the author, so confirm on the journal's own website.
Journal of Advanced Biotechnology and Experimental Therapeutics is published by Bangladesh Society for Microbiology, Immunology and Advanced Biotechnology. Its ISSN is 2616-4760.
No — it is not currently in the Web of Science core collections (SCIE, SSCI, AHCI or ESCI).
Yes — it is an open-access journal, listed in DOAJ.
Journal of Advanced Biotechnology and Experimental Therapeutics has an h-index of 17 and a 2-year mean of 0.98 citations per paper (OpenAlex). Its Scopus CiteScore is 2.1, quartile Q3. On 2-year citations it ranks #306 of 521 Scopus journals in Plant Science.
Journal of Advanced Biotechnology and Experimental Therapeutics published 42 papers in 2025; its busiest recent year was 2022 with 68. 2026* is the year so far.
h-index, i10-index and 2-year mean citedness are open, licence-clear metrics from OpenAlex — not a proprietary impact factor. The subject rank counts only journals that OpenAlex has a figure for; it is not a Scopus or Clarivate ranking. Updated 2026-10-14.
In its latest 45 research articles (2024–2026), authors are most often from Bangladesh (33.3%), Indonesia (16.7%) and Iraq (15.6%).
Countries are counted fractionally, so a paper by authors from two countries counts half to each.
Scopus status: Active. No retracted papers are recorded. The Problematic Paper Screener flags none of its papers. These are indicators to check, not findings against the journal.
Retractions from OpenAlex; flags from the Problematic Paper Screener (Cabanac, Labbé & Magazinov, CC BY), 2026-09-21 export. A flag marks a paper for a closer look; it is not a finding against the journal.
Index data is curated from public sources (Scopus, Web of Science, ABDC, FT50, UT Dallas, DOAJ). CiteScore and quartiles reflect the latest available Scopus release. Always verify a journal's current status on its official source before submitting.
Comments load as you scroll here.